Unequal access to vaccines in the WHO European Region during the A(H1N1) influenza pandemic in 2009
Identifieur interne : 000237 ( PascalFrancis/Corpus ); précédent : 000236; suivant : 000238Unequal access to vaccines in the WHO European Region during the A(H1N1) influenza pandemic in 2009
Auteurs : Pernille Jorgensen ; Annemarie Wasley ; Jolita Mereckiene ; Suzanne Cotter ; J. Todd Weber ; Caroline Sarah BrownSource :
- Vaccine [ 0264-410X ] ; 2013.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Abstract
In a severe pandemic, rapid production and deployment of vaccines will potentially be critical in mitigating the impact on populations and essential services. We compared access to vaccines and timing of delivery relative to identification of A(H1N1)pdm09 and the geographic progression of the pandemic in the WHO European Region in order to identify gaps in provision. Information on vaccine procurement and donations was collected through a web-based survey conducted in all 53 member states of the Region. Among the 51 countries responding to the survey, the majority (84%) implemented vaccination campaigns against A(H1N1)pdm09. However, time of vaccine receipt and number of doses varied substantially across the region, with delayed access in many countries especially in those in the lowest income range. Improving access to influenza vaccines in low resource countries and solving issues of product liability should help reduce inequalities and operational challenges arising during a future public health crisis.
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
pA |
|
---|
Format Inist (serveur)
NO : | PASCAL 13-0280586 INIST |
---|---|
ET : | Unequal access to vaccines in the WHO European Region during the A(H1N1) influenza pandemic in 2009 |
AU : | JORGENSEN (Pernille); WASLEY (Annemarie); MERECKIENE (Jolita); COTTER (Suzanne); TODD WEBER (J.); BROWN (Caroline Sarah) |
AF : | World Health Organization Regional Office for Europe/Copenhagen/Danemark (1 aut., 2 aut., 6 aut.); Health Protection Surveillance Centre/Dublin/Irlande (3 aut., 4 aut.); Centers for Disease Control and Prevention/Atlanta/Etats-Unis (5 aut.) |
DT : | Publication en série; Courte communication, note brève; Niveau analytique |
SO : | Vaccine; ISSN 0264-410X; Coden VACCDE; Royaume-Uni; Da. 2013; Vol. 31; No. 38; Pp. 4060-4062; Bibl. 22 ref. |
LA : | Anglais |
EA : | In a severe pandemic, rapid production and deployment of vaccines will potentially be critical in mitigating the impact on populations and essential services. We compared access to vaccines and timing of delivery relative to identification of A(H1N1)pdm09 and the geographic progression of the pandemic in the WHO European Region in order to identify gaps in provision. Information on vaccine procurement and donations was collected through a web-based survey conducted in all 53 member states of the Region. Among the 51 countries responding to the survey, the majority (84%) implemented vaccination campaigns against A(H1N1)pdm09. However, time of vaccine receipt and number of doses varied substantially across the region, with delayed access in many countries especially in those in the lowest income range. Improving access to influenza vaccines in low resource countries and solving issues of product liability should help reduce inequalities and operational challenges arising during a future public health crisis. |
CC : | 002A05F04; 002A05C10 |
FD : | Virus grippal A; Immunoprophylaxie; Vaccin; Accessibilité; Soin; Europe; Approvisionnement; Grippe A; Pandémie; Virus grippal A(H1N1) |
FG : | Influenzavirus A; Orthomyxoviridae; Virus; Virose; Infection |
ED : | Influenza A virus; Immunoprophylaxis; Vaccine; Accessibility; Care; Europe; Supply; Influenza A; Influenzavirus A(H1N1) |
EG : | Influenzavirus A; Orthomyxoviridae; Virus; Viral disease; Infection |
SD : | Influenza A virus; Inmunoprofilaxia; Vacuna; Accesibilidad; Cuidado; Europa; Aprovisionamiento; Gripe A |
LO : | INIST-20289.354000501937220020 |
ID : | 13-0280586 |
Links to Exploration step
Pascal:13-0280586Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Unequal access to vaccines in the WHO European Region during the A(H1N1) influenza pandemic in 2009</title>
<author><name sortKey="Jorgensen, Pernille" sort="Jorgensen, Pernille" uniqKey="Jorgensen P" first="Pernille" last="Jorgensen">Pernille Jorgensen</name>
<affiliation><inist:fA14 i1="01"><s1>World Health Organization Regional Office for Europe</s1>
<s2>Copenhagen</s2>
<s3>DNK</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Wasley, Annemarie" sort="Wasley, Annemarie" uniqKey="Wasley A" first="Annemarie" last="Wasley">Annemarie Wasley</name>
<affiliation><inist:fA14 i1="01"><s1>World Health Organization Regional Office for Europe</s1>
<s2>Copenhagen</s2>
<s3>DNK</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mereckiene, Jolita" sort="Mereckiene, Jolita" uniqKey="Mereckiene J" first="Jolita" last="Mereckiene">Jolita Mereckiene</name>
<affiliation><inist:fA14 i1="02"><s1>Health Protection Surveillance Centre</s1>
<s2>Dublin</s2>
<s3>IRL</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Cotter, Suzanne" sort="Cotter, Suzanne" uniqKey="Cotter S" first="Suzanne" last="Cotter">Suzanne Cotter</name>
<affiliation><inist:fA14 i1="02"><s1>Health Protection Surveillance Centre</s1>
<s2>Dublin</s2>
<s3>IRL</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Todd Weber, J" sort="Todd Weber, J" uniqKey="Todd Weber J" first="J." last="Todd Weber">J. Todd Weber</name>
<affiliation><inist:fA14 i1="03"><s1>Centers for Disease Control and Prevention</s1>
<s2>Atlanta</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Brown, Caroline Sarah" sort="Brown, Caroline Sarah" uniqKey="Brown C" first="Caroline Sarah" last="Brown">Caroline Sarah Brown</name>
<affiliation><inist:fA14 i1="01"><s1>World Health Organization Regional Office for Europe</s1>
<s2>Copenhagen</s2>
<s3>DNK</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">13-0280586</idno>
<date when="2013">2013</date>
<idno type="stanalyst">PASCAL 13-0280586 INIST</idno>
<idno type="RBID">Pascal:13-0280586</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000237</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Unequal access to vaccines in the WHO European Region during the A(H1N1) influenza pandemic in 2009</title>
<author><name sortKey="Jorgensen, Pernille" sort="Jorgensen, Pernille" uniqKey="Jorgensen P" first="Pernille" last="Jorgensen">Pernille Jorgensen</name>
<affiliation><inist:fA14 i1="01"><s1>World Health Organization Regional Office for Europe</s1>
<s2>Copenhagen</s2>
<s3>DNK</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Wasley, Annemarie" sort="Wasley, Annemarie" uniqKey="Wasley A" first="Annemarie" last="Wasley">Annemarie Wasley</name>
<affiliation><inist:fA14 i1="01"><s1>World Health Organization Regional Office for Europe</s1>
<s2>Copenhagen</s2>
<s3>DNK</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mereckiene, Jolita" sort="Mereckiene, Jolita" uniqKey="Mereckiene J" first="Jolita" last="Mereckiene">Jolita Mereckiene</name>
<affiliation><inist:fA14 i1="02"><s1>Health Protection Surveillance Centre</s1>
<s2>Dublin</s2>
<s3>IRL</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Cotter, Suzanne" sort="Cotter, Suzanne" uniqKey="Cotter S" first="Suzanne" last="Cotter">Suzanne Cotter</name>
<affiliation><inist:fA14 i1="02"><s1>Health Protection Surveillance Centre</s1>
<s2>Dublin</s2>
<s3>IRL</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Todd Weber, J" sort="Todd Weber, J" uniqKey="Todd Weber J" first="J." last="Todd Weber">J. Todd Weber</name>
<affiliation><inist:fA14 i1="03"><s1>Centers for Disease Control and Prevention</s1>
<s2>Atlanta</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Brown, Caroline Sarah" sort="Brown, Caroline Sarah" uniqKey="Brown C" first="Caroline Sarah" last="Brown">Caroline Sarah Brown</name>
<affiliation><inist:fA14 i1="01"><s1>World Health Organization Regional Office for Europe</s1>
<s2>Copenhagen</s2>
<s3>DNK</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Vaccine</title>
<title level="j" type="abbreviated">Vaccine</title>
<idno type="ISSN">0264-410X</idno>
<imprint><date when="2013">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Vaccine</title>
<title level="j" type="abbreviated">Vaccine</title>
<idno type="ISSN">0264-410X</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Accessibility</term>
<term>Care</term>
<term>Europe</term>
<term>Immunoprophylaxis</term>
<term>Influenza A</term>
<term>Influenza A virus</term>
<term>Influenzavirus A(H1N1)</term>
<term>Supply</term>
<term>Vaccine</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Virus grippal A</term>
<term>Immunoprophylaxie</term>
<term>Vaccin</term>
<term>Accessibilité</term>
<term>Soin</term>
<term>Europe</term>
<term>Approvisionnement</term>
<term>Grippe A</term>
<term>Pandémie</term>
<term>Virus grippal A(H1N1)</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">In a severe pandemic, rapid production and deployment of vaccines will potentially be critical in mitigating the impact on populations and essential services. We compared access to vaccines and timing of delivery relative to identification of A(H1N1)pdm09 and the geographic progression of the pandemic in the WHO European Region in order to identify gaps in provision. Information on vaccine procurement and donations was collected through a web-based survey conducted in all 53 member states of the Region. Among the 51 countries responding to the survey, the majority (84%) implemented vaccination campaigns against A(H1N1)pdm09. However, time of vaccine receipt and number of doses varied substantially across the region, with delayed access in many countries especially in those in the lowest income range. Improving access to influenza vaccines in low resource countries and solving issues of product liability should help reduce inequalities and operational challenges arising during a future public health crisis.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0264-410X</s0>
</fA01>
<fA02 i1="01"><s0>VACCDE</s0>
</fA02>
<fA03 i2="1"><s0>Vaccine</s0>
</fA03>
<fA05><s2>31</s2>
</fA05>
<fA06><s2>38</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Unequal access to vaccines in the WHO European Region during the A(H1N1) influenza pandemic in 2009</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>JORGENSEN (Pernille)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>WASLEY (Annemarie)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>MERECKIENE (Jolita)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>COTTER (Suzanne)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>TODD WEBER (J.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>BROWN (Caroline Sarah)</s1>
</fA11>
<fA14 i1="01"><s1>World Health Organization Regional Office for Europe</s1>
<s2>Copenhagen</s2>
<s3>DNK</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Health Protection Surveillance Centre</s1>
<s2>Dublin</s2>
<s3>IRL</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Centers for Disease Control and Prevention</s1>
<s2>Atlanta</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA20><s1>4060-4062</s1>
</fA20>
<fA21><s1>2013</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20289</s2>
<s5>354000501937220020</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2013 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>22 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>13-0280586</s0>
</fA47>
<fA60><s1>P</s1>
<s3>CC</s3>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Vaccine</s0>
</fA64>
<fA66 i1="01"><s0>GBR</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>In a severe pandemic, rapid production and deployment of vaccines will potentially be critical in mitigating the impact on populations and essential services. We compared access to vaccines and timing of delivery relative to identification of A(H1N1)pdm09 and the geographic progression of the pandemic in the WHO European Region in order to identify gaps in provision. Information on vaccine procurement and donations was collected through a web-based survey conducted in all 53 member states of the Region. Among the 51 countries responding to the survey, the majority (84%) implemented vaccination campaigns against A(H1N1)pdm09. However, time of vaccine receipt and number of doses varied substantially across the region, with delayed access in many countries especially in those in the lowest income range. Improving access to influenza vaccines in low resource countries and solving issues of product liability should help reduce inequalities and operational challenges arising during a future public health crisis.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002A05F04</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002A05C10</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Virus grippal A</s0>
<s2>NW</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Influenza A virus</s0>
<s2>NW</s2>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Influenza A virus</s0>
<s2>NW</s2>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Immunoprophylaxie</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Immunoprophylaxis</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Inmunoprofilaxia</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Vaccin</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Vaccine</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Vacuna</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Accessibilité</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Accessibility</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Accesibilidad</s0>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Soin</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Care</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Cuidado</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Europe</s0>
<s2>NG</s2>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Europe</s0>
<s2>NG</s2>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Europa</s0>
<s2>NG</s2>
<s5>09</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Approvisionnement</s0>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Supply</s0>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Aprovisionamiento</s0>
<s5>13</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Grippe A</s0>
<s5>14</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Influenza A</s0>
<s5>14</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Gripe A</s0>
<s5>14</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Pandémie</s0>
<s4>INC</s4>
<s5>86</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Virus grippal A(H1N1)</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Influenzavirus A(H1N1)</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Influenzavirus A</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Influenzavirus A</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Influenzavirus A</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Orthomyxoviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Orthomyxoviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Orthomyxoviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Virose</s0>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Viral disease</s0>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Virosis</s0>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Infection</s0>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Infection</s0>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Infección</s0>
</fC07>
<fN21><s1>266</s1>
</fN21>
</pA>
</standard>
<server><NO>PASCAL 13-0280586 INIST</NO>
<ET>Unequal access to vaccines in the WHO European Region during the A(H1N1) influenza pandemic in 2009</ET>
<AU>JORGENSEN (Pernille); WASLEY (Annemarie); MERECKIENE (Jolita); COTTER (Suzanne); TODD WEBER (J.); BROWN (Caroline Sarah)</AU>
<AF>World Health Organization Regional Office for Europe/Copenhagen/Danemark (1 aut., 2 aut., 6 aut.); Health Protection Surveillance Centre/Dublin/Irlande (3 aut., 4 aut.); Centers for Disease Control and Prevention/Atlanta/Etats-Unis (5 aut.)</AF>
<DT>Publication en série; Courte communication, note brève; Niveau analytique</DT>
<SO>Vaccine; ISSN 0264-410X; Coden VACCDE; Royaume-Uni; Da. 2013; Vol. 31; No. 38; Pp. 4060-4062; Bibl. 22 ref.</SO>
<LA>Anglais</LA>
<EA>In a severe pandemic, rapid production and deployment of vaccines will potentially be critical in mitigating the impact on populations and essential services. We compared access to vaccines and timing of delivery relative to identification of A(H1N1)pdm09 and the geographic progression of the pandemic in the WHO European Region in order to identify gaps in provision. Information on vaccine procurement and donations was collected through a web-based survey conducted in all 53 member states of the Region. Among the 51 countries responding to the survey, the majority (84%) implemented vaccination campaigns against A(H1N1)pdm09. However, time of vaccine receipt and number of doses varied substantially across the region, with delayed access in many countries especially in those in the lowest income range. Improving access to influenza vaccines in low resource countries and solving issues of product liability should help reduce inequalities and operational challenges arising during a future public health crisis.</EA>
<CC>002A05F04; 002A05C10</CC>
<FD>Virus grippal A; Immunoprophylaxie; Vaccin; Accessibilité; Soin; Europe; Approvisionnement; Grippe A; Pandémie; Virus grippal A(H1N1)</FD>
<FG>Influenzavirus A; Orthomyxoviridae; Virus; Virose; Infection</FG>
<ED>Influenza A virus; Immunoprophylaxis; Vaccine; Accessibility; Care; Europe; Supply; Influenza A; Influenzavirus A(H1N1)</ED>
<EG>Influenzavirus A; Orthomyxoviridae; Virus; Viral disease; Infection</EG>
<SD>Influenza A virus; Inmunoprofilaxia; Vacuna; Accesibilidad; Cuidado; Europa; Aprovisionamiento; Gripe A</SD>
<LO>INIST-20289.354000501937220020</LO>
<ID>13-0280586</ID>
</server>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000237 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000237 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= PandemieGrippaleV1 |flux= PascalFrancis |étape= Corpus |type= RBID |clé= Pascal:13-0280586 |texte= Unequal access to vaccines in the WHO European Region during the A(H1N1) influenza pandemic in 2009 }}
This area was generated with Dilib version V0.6.34. |